FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3029983134> ?p ?o ?g. }

• W3029983134 endingPage "1079" @default.
• W3029983134 startingPage "1074" @default.
• W3029983134 abstract "ObjectiveTo investigate the effects of milrinone on levels of inflammatory factors and liver and renal function after CPB in rheumatic heart disease patients for valve replacement.MethodsFrom January 2014 to January 2016, 80 patients received valve replacement in the Central Hospital of Chongqing Three Gorges were randomly divided into observation group and control group by block randomization grouping method, with 40 patients in each group.The patients in the observation group were pumped intravenously with milrinone 0.5μg·kg-1·min-1 for 72h after surgery, while the patients in the control group were not pumped.The serum levels of IL-6, IL-8, IL-10, TNF-α were detected by ELISA before operation and on 0d, 1d, 3d, 5d after operation, respectively.The levels of ALT, AST, Scr were also detected at the same time.Moreover, the time for operation, extracorporeal circulation, interruption, mechanical ventilation, ICU and hospital were also compared between the two groups.ResultsThe levels of TNF-α, IL-6, IL-8 and IL-10 increased immediately after operation in both groups[control group: (14.97±5.14)pg/mL, (52.45±10.37)pg/mL, (34.10±8.38)pg/mL, (32.27±8.45)pg/mL; observation group: (16.05±5.71)pg/mL, (54.39±8.56)pg/mL, (33.80±7.69)pg/mL, (31.48±5.94)pg/mL, t=-0.628, -0.644, 0.116, 0.342], and the peak values of TNF-α, IL-6 and IL-8 reached on the first day after operation in both two groups[control group: (52.07±10.18)pg/mL, (96.04±26.45)pg/mL, (91.14±18.28)pg/mL, (48.10±9.78)pg/mL; observation group: (50.37±12.98)pg/mL, (93.66±24.10)pg/mL, (83.16±16.28)pg/mL, (46.68±9.25)pg/mL, t=0.559, 0.295, 1.458, 0.473], and the peak value of IL-10 reached on the 3rd day after operation(t=-3.577), the differences were statistically significant on the 3rd day after operation[control group: (36.03±9.39)pg/mL, (59.56±14.38)pg/mL, (53.91±13.16)pg/mL, (85.55±16.49)pg/mL; observation group: (36.70±4.33)pg/mL, (36.20±3.85)pg/mL, (42.91±7.30)pg/mL, (101.33±10.81)pg/mL, t=-0.289, 7.017, 3.267, -3.577]. The levels of ALT, AST and Scr increased immediately after operation in both groups[control group: (38.51±5.12)U/L, (40.23±5.03)U/L, (62.27±5.02)μmol/L; observation group: (39.20±4.67)U/L, (39.6±4.94)U/L, (73.61±4.04)μmol/L, t=0.114, 0.243, 0.630], there were tatistically significant difference between the two groups on the 5th day after operation[control group: (61.45±5.27)U/L, (54.20±7.0)U/L, (86.45±9.01)μmol/L; observation group: (36.20±3.85)U/L, (34.85±7.12)U/L, (83.7±11.07)μmol/L, t=11.231, 9.224, 5.647], and on the fifth day, the levels of ALT, AST and Scr in the observation group dropped to normal, while only the level of Scr in the control group dropped to normal.There were no statistically significant differences in the time of operation, extracorporeal circulation, interruption, mechanical ventilation between two groups (t=0.267, 0.151, 0.187, 0.773, all P>0.05). However, there were statistically significant differences in the time of ICU and hospital [control group: (54.90±16.84)h, (14.35±3.01)d, observation group: (44.05±7.06)h, (10±1.86)d, t=8.149, 13.042, all P<0.05].ConclusionMilrinone can obviously improve the inflammatory reaction in surgical trauma tissues caused by IL-6, IL-8, IL-10, TNF-α, and can protect liver, renal tissue from injury, moreover, it can decrease the incidence of postoperative complications and the length of hospital stay.Key words: Rheumatic heart disease; Heart valve prosthesis; Interleukin-6; Interleukin-8; Interleukin-10; Tumor necrosis factor-alpha; Milrinone" @default.
• W3029983134 created "2020-06-05" @default.
• W3029983134 creator A5006596491 @default.
• W3029983134 creator A5008555165 @default.
• W3029983134 creator A5029428171 @default.
• W3029983134 creator A5048387009 @default.
• W3029983134 creator A5053974464 @default.
• W3029983134 creator A5054418515 @default.
• W3029983134 creator A5067902887 @default.
• W3029983134 creator A5080902928 @default.
• W3029983134 creator A5081461782 @default.
• W3029983134 creator A5085007594 @default.
• W3029983134 creator A5091455911 @default.
• W3029983134 date "2019-05-01" @default.
• W3029983134 modified "2023-10-05" @default.
• W3029983134 title "Effects of milrinone on levels of inflammatory factors and liver and renal function after CPB in rheumatic heart disease patients for valve replacement" @default.
• W3029983134 doi "https://doi.org/10.3760/cma.j.issn.1008-6706.2019.09.013" @default.
• W3029983134 hasPublicationYear "2019" @default.
• W3029983134 type Work @default.
• W3029983134 sameAs 3029983134 @default.
• W3029983134 citedByCount "0" @default.
• W3029983134 crossrefType "journal-article" @default.
• W3029983134 hasAuthorship W3029983134A5006596491 @default.
• W3029983134 hasAuthorship W3029983134A5008555165 @default.
• W3029983134 hasAuthorship W3029983134A5029428171 @default.
• W3029983134 hasAuthorship W3029983134A5048387009 @default.
• W3029983134 hasAuthorship W3029983134A5053974464 @default.
• W3029983134 hasAuthorship W3029983134A5054418515 @default.
• W3029983134 hasAuthorship W3029983134A5067902887 @default.
• W3029983134 hasAuthorship W3029983134A5080902928 @default.
• W3029983134 hasAuthorship W3029983134A5081461782 @default.
• W3029983134 hasAuthorship W3029983134A5085007594 @default.
• W3029983134 hasAuthorship W3029983134A5091455911 @default.
• W3029983134 hasConcept C126322002 @default.
• W3029983134 hasConcept C141071460 @default.
• W3029983134 hasConcept C164705383 @default.
• W3029983134 hasConcept C178853913 @default.
• W3029983134 hasConcept C2776229121 @default.
• W3029983134 hasConcept C2776645727 @default.
• W3029983134 hasConcept C2909371484 @default.
• W3029983134 hasConcept C2994232697 @default.
• W3029983134 hasConcept C42219234 @default.
• W3029983134 hasConcept C71924100 @default.
• W3029983134 hasConcept C90924648 @default.
• W3029983134 hasConceptScore W3029983134C126322002 @default.
• W3029983134 hasConceptScore W3029983134C141071460 @default.
• W3029983134 hasConceptScore W3029983134C164705383 @default.
• W3029983134 hasConceptScore W3029983134C178853913 @default.
• W3029983134 hasConceptScore W3029983134C2776229121 @default.
• W3029983134 hasConceptScore W3029983134C2776645727 @default.
• W3029983134 hasConceptScore W3029983134C2909371484 @default.
• W3029983134 hasConceptScore W3029983134C2994232697 @default.
• W3029983134 hasConceptScore W3029983134C42219234 @default.
• W3029983134 hasConceptScore W3029983134C71924100 @default.
• W3029983134 hasConceptScore W3029983134C90924648 @default.
• W3029983134 hasIssue "9" @default.
• W3029983134 hasLocation W30299831341 @default.
• W3029983134 hasOpenAccess W3029983134 @default.
• W3029983134 hasPrimaryLocation W30299831341 @default.
• W3029983134 hasRelatedWork W2349098465 @default.
• W3029983134 hasRelatedWork W2352238664 @default.
• W3029983134 hasRelatedWork W2352549665 @default.
• W3029983134 hasRelatedWork W2355540896 @default.
• W3029983134 hasRelatedWork W2358405673 @default.
• W3029983134 hasRelatedWork W2360226646 @default.
• W3029983134 hasRelatedWork W2363427537 @default.
• W3029983134 hasRelatedWork W2375735204 @default.
• W3029983134 hasRelatedWork W2376574932 @default.
• W3029983134 hasRelatedWork W2377331590 @default.
• W3029983134 hasRelatedWork W2378881688 @default.
• W3029983134 hasRelatedWork W2384781887 @default.
• W3029983134 hasRelatedWork W2388808318 @default.
• W3029983134 hasRelatedWork W2389175781 @default.
• W3029983134 hasRelatedWork W2407564335 @default.
• W3029983134 hasRelatedWork W3025695833 @default.
• W3029983134 hasRelatedWork W3029120156 @default.
• W3029983134 hasRelatedWork W3030261593 @default.
• W3029983134 hasRelatedWork W3031275883 @default.
• W3029983134 hasRelatedWork W3032184171 @default.
• W3029983134 hasVolume "26" @default.
• W3029983134 isParatext "false" @default.
• W3029983134 isRetracted "false" @default.
• W3029983134 magId "3029983134" @default.
• W3029983134 workType "article" @default.